STOCK TITAN

Freshpet (FRPT) CEO exercises 84,000 options and sells 47,582 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freshpet, Inc. Chief Executive Officer William B. Cyr reported a series of option exercises and share sales in Freshpet common stock. He exercised 84,000 options at an exercise price of $10.23 per share and sold 47,582 shares in open-market transactions at prices around $47.52–$47.92 per share.

The filing shows an exercise-and-sell pattern across direct holdings, a spousal account, and two trusts. After these transactions, Cyr holds 204,585 shares directly, with additional indirect holdings including 51,458 shares in the Linda W. Cyr 2020 Irrevocable Trust for Descendants, 55,356 shares in an irrevocable spousal trust, and 22,867 shares held by his spouse.

The sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 5, 2025, and the options exercised were granted under Freshpet’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020.

Positive

  • None.

Negative

  • None.
Insider Cyr William B.
Role Chief Executive Officer
Sold 47,582 shs ($2.28M)
Type Security Shares Price Value
Exercise Options to purchase common stock 62,369 $0.00 --
Exercise Options to purchase common stock 4,620 $0.00 --
Exercise Options to purchase common stock 9,030 $0.00 --
Exercise Options to purchase common stock 7,981 $0.00 --
Exercise Common Stock 62,369 $10.23 $638K
Sale Common Stock 42,907 $47.92 $2.06M
Exercise Common Stock 4,620 $10.23 $47K
Sale Common Stock 999 $47.52 $47K
Exercise Common Stock 9,030 $10.23 $92K
Sale Common Stock 1,951 $47.52 $93K
Exercise Common Stock 7,981 $10.23 $82K
Sale Common Stock 1,725 $47.52 $82K
Holdings After Transaction: Options to purchase common stock — 430,655 shares (Direct, null); Options to purchase common stock — 31,900 shares (Indirect, By Spouse); Common Stock — 247,492 shares (Direct, null); Common Stock — 22,867 shares (Indirect, By Spouse)
Footnotes (1)
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
Shares sold total 47,582 shares Net shares sold across all reported sales transactions
Options exercised 84,000 options Total options converted to common stock at $10.23 exercise price
Exercise price $10.23 per share Strike price for options exercised on common stock
Direct shares after transactions 204,585 shares Direct common stock holdings following the reported trades
Sale price range $47.52–$47.92 per share Prices for open-market sales of common stock
Descendants’ trust holdings 51,458 shares Common shares held by Linda W. Cyr 2020 Irrevocable Trust for Descendants
Irrevocable spousal trust holdings 55,356 shares Common shares held by Irrevocable Spousal Trust for Linda W. Cyr
Spouse holdings 22,867 shares Common shares held indirectly by spouse after transactions
Rule 10b5-1 trading plan financial
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Options to purchase common stock financial
"security_title": "Options to purchase common stock""
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
2014 Omnibus Incentive Plan financial
"The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cyr William B.

(Last)(First)(Middle)
C/O FRESHPET, INC.
1450 US-206

(Street)
BEDMINSTER NEW JERSEY 07921

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/20/2026M62,369A$10.23247,492D
Common Stock05/20/2026S(1)42,907D$47.92204,585D
Common Stock05/20/2026M4,620A$10.2322,867IBy Spouse
Common Stock05/20/2026S(1)999D$47.5221,868IBy Spouse
Common Stock05/20/2026M9,030A$10.2355,356IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock05/20/2026S(1)1,951D$47.5253,405IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock05/20/2026M7,981A$10.2351,458IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock05/20/2026S(1)1,725D$47.5249,733IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options to purchase common stock$10.2305/20/2026M62,369 (2)09/06/2026Common Stock62,369$0430,655D
Options to purchase common stock$10.2305/20/2026M4,620 (2)09/06/2026Common Stock4,620$031,900IBy Spouse
Options to purchase common stock$10.2305/20/2026M9,030 (2)09/06/2026Common Stock9,030$062,350IBy Irrevocable Spousal Trust for Linda W. Cyr
Options to purchase common stock$10.2305/20/2026M7,981 (2)09/06/2026Common Stock7,981$055,095IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
2. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
/s/ Andrew Lampert, as attorney-in-fact for the Reporting Person05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Freshpet (FRPT) CEO William Cyr report?

William Cyr reported exercising 84,000 stock options and selling 47,582 Freshpet common shares. The trades involved direct holdings, a spousal account, and two trusts, reflecting an exercise-and-sell pattern rather than a simple open-market purchase or sale.

At what prices did the Freshpet (FRPT) CEO’s recent stock sales occur?

The reported sales of Freshpet common stock occurred at prices around $47.52 to $47.92 per share. These were open-market transactions executed on the same date as the related option exercises, according to the Form 4 disclosure.

How many options did the Freshpet (FRPT) CEO exercise and at what strike price?

William Cyr exercised 84,000 options to purchase Freshpet common stock at an exercise price of $10.23 per share. These options were granted under Freshpet’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020.

How many Freshpet (FRPT) shares does the CEO hold after these transactions?

Following the reported transactions, William Cyr holds 204,585 Freshpet common shares directly. He also has indirect holdings, including 51,458 shares in a descendants’ trust, 55,356 shares in an irrevocable spousal trust, and 22,867 shares held by his spouse.

Were the Freshpet (FRPT) CEO’s stock sales under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025. Such pre-arranged plans schedule trades in advance, helping separate transaction timing from day-to-day discretionary decisions.

What compensation plan granted the Freshpet (FRPT) CEO’s exercised options?

The exercised options were issued under Freshpet’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020. This indicates the options were long-standing compensation awards rather than newly granted short-term incentives.